Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T05:10:31.679Z Has data issue: false hasContentIssue false
  • English
  • Français

BENEFITS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON QUALITY OF LIFE

Published online by Cambridge University Press:  28 December 2012

Andrea Lukács ,
Emőke Kiss-Tóth ,
Beatrix Varga ,
Andrea Soós ,
Peter Takác  and
László Barkai
Andrea Lukács
Affiliation:
Faculty of Health Care, University of Miskolc
Emőke Kiss-Tóth
Affiliation:
Faculty of Health Care, University of Miskolc
Beatrix Varga
Affiliation:
Faculty of Economics, University of Miskolc
Andrea Soós
Affiliation:
Department of Pediatrics, Borsod County University Hospital, Miskolc
Peter Takác
Affiliation:
Faculty of Health Care, University of Miskolc
László Barkai
Affiliation:
Faculty of Health Care, University of Miskolc; Postgraduate Institute of Pediatrics, Medical and Health Science Center, University of Debrecen
Get access Rights & Permissions [Opens in a new window]

Abstract

Purpose: The aim of this study was to compare the general health-related quality of life (HRQoL), the metabolic control (HbA1c), the anthropometric measurement, and the cardiorespiratory fitness (expressed by VO2max) in youths with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) to those receiving multiple daily injections (MDI). We looked for factors influencing the HRQoL and metabolic control.

Methods: A total of 239 patients treated with CSII (51 girls and 53 boys) or MDI (64 girls and 71 boys) between ages 8 and 18 years were assessed with the Pediatric Quality of Life Inventory, Generic Core Scales, and Diabetes Module. VO2max was evaluated using the 20-meter shuttle run test.

Results: CSII group had significantly better HRQoL according to both child self-report and parent proxy-report. Youths with CSII reported better physical, emotional, and school-related functioning, and had less diabetes-related fear and symptoms than the MDI group. There were no significant differences in body mass index z-scores, insulin doses, HbA1c, and VO2max between the groups. HRQoL was predicted by the CSII therapy (β = −0.220; p = .000) and the VO2max (β = 0.386; p = .000), other clinical and anthropometric parameters had no effect; the HbA1c was predicted only by VO2max (β = −0.353; p = .000).

Conclusions: Diabetic youths treated with CSII therapy have better HRQoL than those treated with MDI. There are no differences between the investigated groups in anthropometric data, glycated hemoglobin, and physical fitness. Moreover, good physical fitness has an important role in achieving better metabolic control and HRQoL, which underlines the importance of regular aerobic exercise in the treatment and care of type 1 diabetes in childhood.

Keywords

Type 1 diabetes mellitusChildrenAdolescentsHealth-related quality of lifeContinuous subcutaneous insulin infusion
Type
ASSESSMENTS
Information
International Journal of Technology Assessment in Health Care , Volume 29 , Issue 1 , January 2013 , pp. 48 - 52
Copyright
Copyright © Cambridge University Press 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Soltesz, G, Patterson, CC, Dahlquist, G; (EURODIAB Study Group). Worldwide childhood type 1 diabetes incidence – what can we learn from epidemiology? Pediatr Diabetes. 2007;8 (Suppl 6):6–14.CrossRefGoogle Scholar
2.Bangstad, H-J, Danne, T, Deeb, LC, et al.Insulin treatment in children and adolescents with diabetes (ISPAD Clinical Practice Consensus Guidelines 2009 Compendium). Pediatr Diabetes. 2009;10 (Suppl 12):82–99.CrossRefGoogle Scholar
3.Tamborlane, WV, Sherwin, RS, Genel, M, Felig, P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300:573–8.CrossRefGoogle ScholarPubMed
4.Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1994;125:177–88.CrossRefGoogle Scholar
5.Phillip, M, Battelino, T, Rodriguez, H, Danne, T, Kaufman, F. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society, International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007;30:1653–62.CrossRefGoogle ScholarPubMed
6.Wilson, DM, Buckingham, BA, Kunselman, EL, et al.A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care. 2005;28:15–9.CrossRefGoogle ScholarPubMed
7.Monami, M, Lamanna, C, Marchionni, N, Mannucci, E. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol. 2010;47 (Suppl 1):77–81.CrossRefGoogle ScholarPubMed
8.Misso, ML, Egberts, KJ, Page, M, O'Connor, D, Shaw, J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010;1:CD005103.Google Scholar
9.Cummins, E, Royle, P, Snaith, A, et al.Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess. 2010;14:iii–iv, xi–xvi, 1–181.CrossRefGoogle ScholarPubMed
10.Golden, SH, Brown, T, Yeh, HCet al., Methods for insulin delivery and glucose monitoring: comparative effectiveness. Comparative Effectiveness Review No. 57. (Prepared by Johns Hopkins University Evidence-based Practice Center under Contract No 290-2007-10061-I.) AHRQ Publication No. 12-EHC036-EF, Rockville, MD: Agency for Healthcare Research and Quality. [cited 2012 July]. Available from: www.effetivehealthcare.ahrq.gov/reports/final.cfm.Google Scholar
11.American Diabetes Association. Physical activity/exercise and diabetes mellitus. Diabetes Care. 2004;27 (Suppl 1):S58–62.CrossRefGoogle Scholar
12.Peirce, NS. Diabetes and exercise. Br J Sports Med. 1999;33:161–73.CrossRefGoogle ScholarPubMed
13.Rigla, M, Sánchez-Quesada, JL, Ordóñez-Llanos, J, et al.Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients. Metabolism. 2000;49:640–7.CrossRefGoogle ScholarPubMed
14.Komatsu, WR, Gabbay, MA, Castro, ML, et al.Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus. Pediatr Diabetes. 2005;6:145–9.CrossRefGoogle ScholarPubMed
15.Williams, BK, Guelfi, KJ, Jones, TW, Davis, EA. Lower cardiorespiratory fitness in children with type 1 diabetes. Diabet Med. 2011;28:1005–7.CrossRefGoogle ScholarPubMed
16.Varni, JW, Seid, M, Kurtin, PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.CrossRefGoogle ScholarPubMed
17.Varni, JW, Burwinkle, MA, Jacobs, JR, et al.The PedsQL™ in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and type 1 Diabetes Module. Diabetes Care. 2003;26:631–637.CrossRefGoogle ScholarPubMed
18.Léger, LA, Mercier, D, Gadoury, C, Lambert, J. The multistage 20 metre shuttle run test for aerobic fitness. J Sports Sci. 1988;6:93–101.CrossRefGoogle ScholarPubMed
19.Liu, NY, Plowman, SA, Looney, MA. The reliability and validity of the 20-meter shuttle test in American students 12 to 15 years old. Res Q Exerc Sport. 1992;63:360–5.CrossRefGoogle ScholarPubMed
20.Kenney, L, Wilmore, JH, Costill, DL. Physiology of Sport and Exercise. 5th ed.Champaign, IL: Human Kinetics; 2005:269.Google Scholar
21.Hungarian National Institute of Child Health. [cited 2012 April 18]. Available from: http://www.ogyei.hu/upload/files/gyermekkoriTaplaltsag.pdf.Google Scholar
22.Naughton, MJ, Ruggiero, MS, Lawrence, JM, et al.(SEARCH for Diabetes in Youth Study). Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus. Arch Pediatr Adolesc Med. 2008;162:649–57.CrossRefGoogle ScholarPubMed
23.Bode, BW, Tamborlane, WV, Davidson, PC. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med. 2002;111:69–77.CrossRefGoogle ScholarPubMed
24.Pańkowska, E, Błazik, M, Dziechciarz, P, Szypowska, A, Szajewska, H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10:52–8.CrossRefGoogle ScholarPubMed
25.Barnard, K, Thomas, S, Royle, P, Noyes, K, Waugh, N. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr. 2010;10:50.CrossRefGoogle ScholarPubMed
26.McGarthy, M. The everything parent's guide to children with juvenile diabetes: reassuring advice for managing symptoms and raising a healthy, happy child. New York: Adams Media and F+W Publications Company; 2007:33.Google Scholar